| Blake Barney, MS, ACADC | |
|
1309 Camas St, Blackfoot, ID 83221-3060 | |
| (208) 782-0675 | |
| Not Available |
| Full Name | Blake Barney |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 1309 Camas St, Blackfoot, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861835597 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Blake Barney, MS, ACADC 325 Pearl St, Pocatello, ID 83201-3520 Ph: (208) 569-6799 | Blake Barney, MS, ACADC 1309 Camas St, Blackfoot, ID 83221-3060 Ph: (208) 782-0675 |
News Archive
The U.S. Food and Drug Administration (FDA) today issued draft regulatory guidance for industry and clinical laboratories for a new type of medical test.
Study participants who reported tobacco use or had higher levels of biomarkers of tobacco exposure had a higher prevalence of the sexually transmitted infection, oral human papillomavirus type 16 (HPV-16), according to a study in the October 8 JAMA, a theme issue on infectious disease.
An advisory panel from the United States Food and Drug Administration (FDA) has recommended the approval of a novel epilepsy drug that is made up of ingredients from marijuana. The agency normally follows the recommendations of the advisory panels regarding approvals and rejections of applications of new drugs. The recommendation statement came yesterday (19th April 2018).
Cancer Research UK will join forces with international research groups from the UK, Europe and the US to launch an initiative to boost the development of new treatments for patients with rare cancers. The announcement will be made by Dr Harpal Kumar, chief executive of Cancer Research UK, at the 2011 World Cancer Leaders' Summit taking place today in Dublin.
On May 27, researchers with the National Human Genome Research Institute and the National Cancer Institute, along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."
› Verified 4 days ago
Shayna Kearn Norton, LMFT, CADC Counselor Medicare: Medicare Enrolled Practice Location: 288 N Shilling Ave, Blackfoot, ID 83221 Phone: 208-785-1047 | |
Ms. Suzanne Godfrey, LCPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 98 Poplar St, Third Floor, Blackfoot, ID 83221 Phone: 208-785-3800 Fax: 208-785-3876 | |
Kimberley Sweet, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 720 East Alice Street, Blackfoot, ID 83221 Phone: 208-785-5874 | |
David Scott Hurst, LPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1309 Camas St, Blackfoot, ID 83221 Phone: 208-782-0678 | |
Dallen Ray Bell, LMSW Counselor Medicare: Medicare Enrolled Practice Location: 1309 Camas St, Blackfoot, ID 83221 Phone: 208-782-0675 Fax: 208-782-0678 | |
Mrs. Kathleen S Tomazin, LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 90 W Judicial St, Blackfoot, ID 83221 Phone: 208-782-2060 Fax: 208-782-0209 | |
Ruby Lee Walker, LPCP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1441 Parkway Dr, Blackfoot, ID 83221 Phone: 208-785-2600 |